- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Maximally tolerated dose
Total 21007 results
-
Danae Hamouda, MDRecruitingAdvanced Solid Tumor | Advanced Pancreatic CancerUnited States
-
Cosmo Technologies LtdRecruitingAdvanced Refractory Solid Tumors | Subjects Considered Likely to Respond to CB-03-10United States
-
Institut BergoniéMerck Sharp & Dohme LLC; National Cancer Institute, France; Transgene; Fondation...RecruitingBreast Cancer | Soft-tissue Sarcoma | Solid TumorsFrance
-
National Cancer Institute (NCI)RecruitingSarcoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Neurofibroma, Plexiform | Leukemia, Promyelocytic, AcuteUnited States
-
Plus TherapeuticsNational Cancer Institute (NCI)Recruiting
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustRecruiting
-
National Cancer Institute (NCI)Active, not recruitingNeurofibromatosis 1 | Neurofibroma, Plexiform | Neurofibromatosis Type 1 | NF1United States
-
Eisai Co., Ltd.Active, not recruiting
-
Regeneron PharmaceuticalsActive, not recruiting
-
Boehringer IngelheimCompleted
-
Noxopharm LimitedTerminatedMetastatic Castration-resistant Prostate Cancer and Other Solid TumorsUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedAcute Myeloid LeukaemiaUnited States, Australia, France, Spain
-
Boehringer IngelheimActive, not recruiting
-
University of Colorado, DenverActive, not recruitingHigh Grade Myelodysplastic SyndromesUnited States
-
Boehringer IngelheimCompleted
-
M.D. Anderson Cancer CenterActive, not recruitingAdvanced CancersUnited States
-
University of Maryland, BaltimoreActive, not recruitingRelapsed or Refractory Acute Myeloid LeukemiaUnited States
-
BayerMerck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Spain, Germany, Switzerland, United Kingdom
-
Boehringer IngelheimCompleted
-
Cedars-Sinai Medical CenterActive, not recruitingBrain MetastasesUnited States
-
SanofiCompletedParoxysmal Nocturnal HemoglobinuriaUnited States
-
Shenzhen NewDEL Biotech, Co., LtdShenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.Enrolling by invitation
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia | Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaGermany, Australia, Netherlands, Spain, Korea, Republic of, France, Japan, Italy, Singapore, United States
-
University of Maryland, BaltimoreActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
SkinJect, Inc.Terminated
-
HiberCell, Inc.CovanceCompletedRenal Cell Carcinoma | Gastric Cancer | Metastatic Breast Cancer | Small-cell Lung Cancer | Other Solid TumorsUnited States
-
Boehringer IngelheimCompleted
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
Boehringer IngelheimActive, not recruiting
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.Terminated
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsCompletedAtherosclerotic Cardiovascular DiseaseUnited States
-
Bliss Biopharmaceutical (Hangzhou) Co., LtdActive, not recruitingLocally Advanced/Metastatic HER2 Positive Solid TumorsChina, United States
-
Boehringer IngelheimCompletedDepressive Disorder, MajorUnited States
-
Boehringer IngelheimCompleted
-
M.D. Anderson Cancer CenterIncyte CorporationCompletedLeukemiaUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimActive, not recruiting
-
Konkuk University Medical CenterChonbuk National University Hospital; Samsung Medical Center; Pusan National... and other collaboratorsActive, not recruitingSafety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia (IDAML)Leukemia, Myeloid, AcuteKorea, Republic of
-
M.D. Anderson Cancer CenterMedImmune LLCTerminated
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Brain Cancer | Brain MetastasisUnited States
-
Royal Marsden NHS Foundation TrustAstraZeneca; Cancer Research UK; RM/ICR Biomedical Research CentreActive, not recruitingSolid Tumour Refractory to Conventional TreatmentUnited Kingdom